(Q36330953)
Statements
Risk of local adverse events following cardiac catheterization by hemostasis device use - phase II (English)
Dale R Tavris
Syamal Dey
Beverly Albrecht-Gallauresi
Ralph G Brindis
Richard Shaw
William Weintraub